Safety profile of tyrosine kinase inhibitors used in non-small-cell lung cancer: An analysis from the Italian pharmacovigilance database

Overview of attention for article published in Frontiers in oncology, November 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (62nd percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 16 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 6 X posts from 5 X users, with an upper bound of 27,315 followers.

RT @FrontOncology: New research: Safety profile of tyrosine kinase inhibitors used in non-small-cell lung cancer: An analysis from the Ital…

09 Jan 2023

Reply Repost Favourite

Safety profile of tyrosine kinase inhibitors used in non-small-cell lung cancer: An analysis from the Italian pharmacovigilance database #lymphoma #lymsm https://t.co/8iYpp8PC0L

12 Dec 2022

Reply Repost Favourite

Safety profile of tyrosine kinase inhibitors used in non-small-cell lung cancer: An analysis from the Italian pharmacovigilance database https://t.co/UHAmBnRXHN https://t.co/CWaiOp4gAq

26 Nov 2022

Reply Repost Favourite

Our new article on Frontiers in Oncology!!! Safety profile of tyrosine kinase inhibitors used in non-small-cell lung cancer: An analysis from the Italian pharmacovigilance database https://t.co/1sFXrgBW9E

23 Nov 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.